ArticleYonsei medical journal2016

Survival Outcomes of Concurrent Treatment with Docetaxel and Androgen Deprivation Therapy in Metastatic Castration-Resistant Prostate Cancer.

Ho Seong Jang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.